Spaid John L 4/A

What Happened John L. Spaid, Chief Financial Officer and EVP Finance of National Health Investors, received an award of 5,072 shares on March 3, 2026. The shares were reported at a $0.00 acquisition price (common for compensation awards where no cash outlay by the insider is required). This Form 4/A amends a prior filing to correct an administrative understatement of 346 shares in the original report.

Key Details

• Transaction date: 2026-03-03; transaction type: Award/Grant (code A).
• Price reported: $0.00 per share; total reported value: $0.
• Amendment: Form 4/A filed 2026-03-30 to correct the previously understated award (footnote F1).
• Shares owned after transaction: the filing references footnote F2 as the total owned after 03/03/2026 transactions; the exact total owned figure was not provided in the summary data here.
• Timeliness: The Form 4 was amended and filed on 2026-03-30 for a 03/03/2026 transaction — this is an amended (late-correcting) filing.

Context Stock awards to executives are typically part of compensation or retention programs and do not represent an open‑market purchase or sale. Such awards often vest over time and therefore are not a direct signal of immediate buying or selling intent. The amendment simply corrects the reported share count and does not imply additional trading activity.